OrbiMed’s Otonomy, Inc. OTIC Stock Holding History

OrbiMed’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,250,000	Closed	-$7.25M	–	187
2021 Q2	$7.25M	Hold	3,250,000	–	–	0.07%	140
2021 Q1	$8.29M	Hold	3,250,000	–	–	0.08%	128
2020 Q4	$21M	Hold	3,250,000	–	–	0.18%	100
2020 Q3	$13.2M	Buy	+3,250,000	New	+$12.3M	0.17%	102
2020 Q2	–	Sell	-71,994	Closed	-$142K	–	164
2020 Q1	$142K	Sell	71,994 -278,706	-79%	-$859K	﹤0.01%	141
2019 Q4	$1.34M	Buy	+350,700	New	+$857K	0.02%	126
2017 Q4	–	Sell	-644,074	Closed	-$2.09M	–	150
2017 Q3	$2.09M	Sell	644,074 -915,000	-59%	-$12.3M	0.02%	129
2017 Q2	$29.4M	Sell	1,559,074 -291,020	-16%	-$4.06M	0.31%	72
2017 Q1	$22.7M	Hold	1,850,094	–	–	0.26%	76
2016 Q4	$29.4M	Hold	1,850,094	–	–	0.37%	58
2016 Q3	$33.7M	Hold	1,850,094	–	–	0.38%	61
2016 Q2	$29.4M	Hold	1,850,094	–	–	0.31%	64
2016 Q1	$27.6M	Hold	1,850,094	–	–	0.29%	60
2015 Q4	$51.3M	Sell	1,850,094 -406,304	-18%	-$10.1M	0.46%	53
2015 Q3	$40.2M	Hold	2,256,398	–	–	0.41%	50
2015 Q2	$51.9M	Hold	2,256,398	–	–	0.43%	53
2015 Q1	$79.8M	Hold	2,256,398	–	–	0.68%	43
2014 Q4	$75.2M	Hold	2,256,398	–	–	0.72%	38
2014 Q3	$54.2M	Buy	+2,256,398	New	+$44.6M	0.57%	44

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed's OTIC Position: Q3 2021 in Review

OrbiMed sold out of Otonomy, Inc. (OTIC) in Q3 2021, closing a stake of 3,250,000 shares — an estimated $7.25M sold.

OrbiMed first reported a position in OTIC in Q3 2014 and held it in 19 quarters. The position peaked at $79.8M in Q1 2015. 55 funds tracked by Wall St. Rank hold OTIC as of Q3 2021.

OrbiMed reported no remaining Otonomy, Inc. position as of Q3 2021 after selling out during the quarter.
OrbiMed sold 3,250,000 Otonomy, Inc. shares in Q3 2021, an estimated $7.25M.
OrbiMed first reported a position in Otonomy, Inc. in Q3 2014 and held it in 19 quarters.
OrbiMed's Otonomy, Inc. position peaked at $79.8M in Q1 2015.
55 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2021.

Based on OrbiMed's 13F filing for Q3 2021, filed 15 Nov 2021.